What is Kidney Beam?
Kidney Beam operates as a specialized digital health platform, providing clinically-validated exercise, education, and well-being resources tailored specifically for individuals living with CKD. Developed in strategic partnership with Kings College Hospital London, the platform bridges the gap between traditional clinical care and accessible, home-based wellness. By utilizing live and on-demand programming led by physiotherapists and exercise professionals—many of whom possess specialized training or personal experience with CKD—Kidney Beam offers a unique, patient-centric model. This approach not only improves physical outcomes but also fosters a supportive community, positioning the company as a leader in the digital therapeutics sector for renal health.
How much funding has Kidney Beam raised?
Kidney Beam has raised a total of $762K across 1 funding round:
Angel/Seed
$762K
Angel/Seed (2025): $762K with participation from Sheffield Area Kidney Association, National Kidney Foundation, and Kidney Research UK
Key Investors in Kidney Beam
Sheffield Area Kidney Association
A regional charity focused on supporting kidney patients and their families through resource provision and community engagement.
National Kidney Foundation
An international organization dedicated to the eradication of renal cancers and the advancement of kidney health research.
Kidney Research UK
The leading UK-based charity focused on funding research to transform treatments and improve the lives of those affected by kidney disease.
What's next for Kidney Beam?
With this major enterprise-level funding, Kidney Beam is poised to accelerate its growth trajectory by scaling its digital platform to reach a broader international patient base. The strategic roadmap likely includes deepening its integration with healthcare providers, expanding its library of specialized content, and investing in data-driven outcomes research to further validate its clinical efficacy. As the demand for remote, condition-specific health management continues to rise, Kidney Beam is strategically positioned to capture significant market share, potentially setting a new standard for how chronic disease management is delivered in a digital-first environment.
See full Kidney Beam company page
